menu
    • menu

    Company profile for Grid Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapeutic antibodies for cancer. Grid has a unique and innovative platform to discover human-derived antibodies against novel tumor-specific targets, and can rapidly translate these findings into clinical practice. The Management Team was a...
    Grid Therapeutics is an emerging clinical stage biotechnology company located in Durham, North Carolina. We have made a commitment to our patients and families to develop better and safer therapeutic antibodies for cancer. Grid has a unique and innovative platform to discover human-derived antibodies against novel tumor-specific targets, and can rapidly translate these findings into clinical practice. The Management Team was assembled to rapidly advance these assets to the clinic and have the skillsets and experience to deliver a unique portfolio in the immune-oncology space.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Grid TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Research Triangle, East Coast, Southern US
    Telephone
    Telephone
    919-987-7190
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://gridtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Infinimmune Announces Partnership with Grid Therapeutics
    Infinimmune Announces Partnership with Grid Therapeutics

    19 Dec 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231219029783/en

    BUSINESSWIRE
    19 Dec 2023
    Share Share
    Grid Therapeutics begins Phase II trial of NSCLC therapy
    Grid Therapeutics begins Phase II trial of NSCLC therapy

    24 Feb 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/grid-therapeutics-nsclc-therapy/

    CLINICAL TRIALS ARENA
    24 Feb 2023
    Share Share
    Grid Initiates PII Investigator-Sponsored Trial of GT103 with Pembrolizumab
    Grid Initiates PII Investigator-Sponsored Trial of GT103 with Pembrolizumab

    22 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230222005047/en

    BUSINESSWIRE
    22 Feb 2023
    Share Share
    Grid Therapeutics Announces Presentation at the SITC 37th Annual Meeting
    Grid Therapeutics Announces Presentation at the SITC 37th Annual Meeting

    03 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221103005310/en

    BUSINESSWIRE
    03 Nov 2022
    Share Share
    Grid Therapeutics Announces Enrollment of First Patient in Ph1 Study of GT103
    Grid Therapeutics Announces Enrollment of First Patient in Ph1 Study of GT103

    24 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200624005139/en

    BUSINESSWIRE
    24 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search